Evidence map›Paper›PMID 36132957›Full record

ArticleNanoscale advances2021

Synthesis of SERS-active core-satellite nanoparticles using heterobifunctional PEG linkers.

Angela Michelle T San Juan, Suhash Reddy Chavva, Dandan Tu, Melanie Tircuit, Gerard Coté, Samuel Mabbott

Open access · goldAbstract read
In one paragraph

Article in Nanoscale advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Angela Michelle T San JuanTexas A&M University Health Technologies and Innovations Building, 3006 TAMU College Station Texas 77843 USA smabbott@tamu.edu.ORCID https://orcid.org/0000-0001-7502-3133
Suhash Reddy ChavvaTexas A&M University Health Technologies and Innovations Building, 3006 TAMU College Station Texas 77843 USA smabbott@tamu.edu.
Dandan TuTexas A&M University Health Technologies and Innovations Building, 3006 TAMU College Station Texas 77843 USA smabbott@tamu.edu.ORCID https://orcid.org/0000-0003-3827-6486
Melanie TircuitTexas A&M University Health Technologies and Innovations Building, 3006 TAMU College Station Texas 77843 USA smabbott@tamu.edu.
Gerard CotéTexas A&M University Health Technologies and Innovations Building, 3006 TAMU College Station Texas 77843 USA smabbott@tamu.edu.ORCID https://orcid.org/0000-0002-3164-9625
Samuel MabbottTexas A&M University Health Technologies and Innovations Building, 3006 TAMU College Station Texas 77843 USA smabbott@tamu.edu.ORCID https://orcid.org/0000-0003-4926-5467
Texas A&M University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surface-enhanced Raman scattering (SERS) is a sensitive analytical technique capable of magnifying the vibrational intensity of molecules adsorbed onto the surface of metallic nanostructures. Various solution-based SERS-active metallic nanostructures have been designed to generate substantial SERS signal enhancements. However, most of these SERS substrates rely on the chemical aggregation of metallic nanostructures to create strong signals. While this can induce high SERS intensities through plasmonic coupling, most chemically aggregated assemblies suffer from poor signal reproducibility and reduced long-term stability. To overcome these issues, here we report for the first time the synthesis of gold core-satellite nanoparticles (CSNPs) for robust SERS signal generation. The novel CSNP assemblies consist of a 30 nm spherical gold core linked to 18 nm satellite particles

Identifiers

PMID36132957
PMCPMC9417690
OpenAlexW3213913195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.